- Jun 24, 2021 8:00 pm
- 17:15
There’s a simple screening for people with sickle cell disease that can prevent strokes. There’s also medication for significant sickle cell disease effects. So why are less than half of patients getting screened—and why have some patients never even heard of the medication? Dr. Julie Kanter of the University of Alabama-Birmingham and its Adult Sickle Cell Clinic explores sickle cell disease research’s chronic state of underfunding.
Related Links
Long COVID-19
Nearly a quarter of Americans who caught COVID-19 sought medical treatment for a new health problem a month or more after getting COVID. And it’s not just people who had a severe reaction to the virus – even some asymptomatic individuals are seeing some long-term effects. Epidemiologist and Director at Veterans Affairs St. Louis Healthcare System Dr. Ziyad Al-Aly fears that COVID-19 “long-haulers” are victims of a new, long-term health crisis. (AP Photo/Marco Ugarte)
Nearly a quarter of Americans who caught COVID-19 sought medical treatment for a new health problem a month or more after getting COVID. And it’s not just people who had a severe reaction to the virus – even some asymptomatic individuals are seeing some long-term effects. Epidemiologist and Director at Veterans Affairs St. Louis Healthcare System Dr. Ziyad Al-Aly fears that COVID-19 “long-haulers” are victims of a new, long-term health crisis. (AP Photo/Marco Ugarte)
Sickle Cell Inequity
There’s a simple screening for people with sickle cell disease that can prevent strokes. There’s also medication for significant sickle cell disease effects. So why are less than half of patients getting screened—and why have some patients never even heard of the medication? Dr. Julie Kanter of the University of Alabama-Birmingham and its Adult Sickle Cell Clinic explores sickle cell disease research’s chronic state of underfunding.
There’s a simple screening for people with sickle cell disease that can prevent strokes. There’s also medication for significant sickle cell disease effects. So why are less than half of patients getting screened—and why have some patients never even heard of the medication? Dr. Julie Kanter of the University of Alabama-Birmingham and its Adult Sickle Cell Clinic explores sickle cell disease research’s chronic state of underfunding.
Indigenous American Food Insecurity
Since COVID-19, American food insecurity rates have been climbing, and Native Americans have it the worst—one in four doesn’t have reliable access to food, particularly healthy food. Native Americans are much more likely than white Americans to experience obesity, heart disease, or diabetes. Tara Maudrie is researching this problem. Maudrie is a Ph.D. student in public health at Johns Hopkins University.
Since COVID-19, American food insecurity rates have been climbing, and Native Americans have it the worst—one in four doesn’t have reliable access to food, particularly healthy food. Native Americans are much more likely than white Americans to experience obesity, heart disease, or diabetes. Tara Maudrie is researching this problem. Maudrie is a Ph.D. student in public health at Johns Hopkins University.
Memory Thief
The FDA just approved a new drug to treat Alzheimer’s. But how well the drug actually works to slow cognitive decline and memory loss in Alzheimer’s patients is still unclear. Science journalist Lauren Aguirre's new book, “The Memory Thief: And the Secrets Behind How We Remember,” explains why treatment for memory loss conditions like Alzheimer’s has been so hard to come by. She tells it like a detective story centered on a small cluster of patients who showed up in emergency rooms over the last several years with absolutely no short-term memory.
The FDA just approved a new drug to treat Alzheimer’s. But how well the drug actually works to slow cognitive decline and memory loss in Alzheimer’s patients is still unclear. Science journalist Lauren Aguirre's new book, “The Memory Thief: And the Secrets Behind How We Remember,” explains why treatment for memory loss conditions like Alzheimer’s has been so hard to come by. She tells it like a detective story centered on a small cluster of patients who showed up in emergency rooms over the last several years with absolutely no short-term memory.
Creative Anxiety
How would you feel if you were asked to come up with an innovative solution to a problem at work? New research shows that the more anxious you feel about being creative, the less creative you are. Richard Daker is studying this “creative anxiety” at Georgetown University, where he’s a Ph.D. student in relational cognition.
How would you feel if you were asked to come up with an innovative solution to a problem at work? New research shows that the more anxious you feel about being creative, the less creative you are. Richard Daker is studying this “creative anxiety” at Georgetown University, where he’s a Ph.D. student in relational cognition.